Microbioz India: February 2021
A short Q&A with our CEO, Mark Copley, on inhaled product testing
View ArticleONdrugDelivery Article: November 2020
Semi-Automation in Inhaler Testing – Exploring the Potential and Practicalities In this article, João Pereira, Team Leader R&am…
View ArticleInhalation Article: December 2019
Optimizing the role of automation in variability reduction strategies for delivered dose uniformity (DDU) and aerodynamic particle…
View ArticlePoster: December 2019
Investigation of DPI particle microstructure by MDRS to explain the difference observed in NGI results between equivalent products
View ArticleInhalation Article: April 2019
The regulatory landscape for OINDPs – the biggest shake-up in a generation?
View ArticleONdrugDelivery Article: December 2018
Variability in cascade impaction: sources, impact and strategies for reduction In this article, Mark Copley, Chief Executive Offic…
View ArticleWhite Paper: October 2018
Analysis technology for inhalation product testing [article in Chinese]
View ArticleDrug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
View ArticlePMPS Article (Samedan): February 2018
Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a g…
View ArticleWhite Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
View ArticleAmerican Pharmaceutical Review Article: Nov/Dec 2017
Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing
View Article